Navigation Links
Samarion(SM) to Have Major Presence at the AHCA/NACL/MECF 59th Annual Convention & Expo
Date:10/1/2008

SamarionSolution(SM) Provides Comprehensive Solution to Complex Nursing

Home Challenges

NASHVILLE, Tenn., Oct. 1 /PRNewswire/ -- Samarion Inc., the Long Term Care (LTC) industry's technology partner, will demonstrate SamarionSolution(SM), an enterprise quality improvement system that will help nursing home facilities reduce falls, reduce incidents of wandering and elopement, eliminate the environment for abuse and neglect, and effectively manage staff efficiency and performance.

The company will host live presentations of this system at Booth #401 at the AHCA/NACL/MECF 59th Annual Convention and Exposition Oct. 5-8 at the Gaylord Opryland Resort & Convention Center in Nashville, Tenn.

"Every stakeholder in long term care, from resident rights organizations to regulators and even industry associations, has called for new technologies to support quality improvements," said Mark E. Rodgers, Samarion CEO. "At the AHCA annual convention, we invite all of these stakeholders to personally confirm that Samarion has answered the call, and to see how together we can fundamentally change the overall quality of care in nursing homes. In fact, together we will redefine long term care."

To experience SamarionSolution, the Samarion team of experts-plus owners and administrators of nursing homes who have initial implementations of SamarionSolution -- will be on hand at Booth #401 to demonstrate the system, sign up customers, and book installations.

Samarion will also demonstrate SamarionSolution at the 2008 AAHSA 2008 Annual Meeting and Exposition Oct. 12-15 at the Pennsylvania Convention Center in Philadelphia, Pa.

Samarion, a privately-held corporation dedicated to improving the quality of elder care, was recognized early on as an "Emerging High-Growth Company to Watch." Mark E. Rodgers serves as commissioner for the Center for Aging Services Technologies (CAST), an international coalition leading the
'/>"/>

SOURCE Samarion Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Samarion(SM) to Demonstrate Unprecedented Fall Prevention Component of Enterprise Quality Improvement System for LTC Facilities at the AAHSA 2008 Annual Meeting & Exposition
2. Samarion(SM) Announces Second Outcome Based Study Partner Site for LTC Industrys Only Enterprise Quality Improvement System
3. Samarion(SM) Announces Formation of Outcome Based Study Team for Industrys Only Enterprise Quality Improvement System
4. Facet joint effusion and interspinal ligament edema: major sources of lower back pain
5. The Leukemia & Lymphoma Society Awards Major Grant to Stanford Researcher
6. TrakSoft LLC Announces the Release of Contract Analyst, Version 3.0, a Contract Management System, which Includes a Major User Customization Upgrade
7. Catholic Health Initiatives Makes Major Gift to Support Affordable Housing in the Midwest
8. Majority of children vaccinated against hepatitis B not at increased risk of MS
9. Swiss Institute of Bioinformatics announces major breakthrough
10. E-mergency? Majority of U.S. Consumers Lack Essential Vitamin E
11. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:DecisionView Launches StudyOptimizer(TM) 4 2DecisionView Launches StudyOptimizer(TM) 4 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 1Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 2Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 3Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 4Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients 4558 5StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 1StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 2StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 3StayWell Custom Communications Announces Strategic Alliance with Siteimprove 48133 4National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 1National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 2National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 3National Marrowthon Campaign Aims to Bring Nearly 50 000 to the Be The Match Registry 28SM 29 in Two Weeks 48131 4